Associate Professor Salmaan Qureshi is the head of the Royal Victorian Eye and Ear Hospital’s (RVEEH) Medical Retina service. A/Prof Qureshi chairs the Eye Hospital’s nationally recognized weekly “Angiogram Meeting”. He is also an Associate Professor of Ophthalmology at the Centre for Eye Research Australia at the University of Melbourne. He was until 2020 the Editor in Chief of Clinical and Experimental Ophthalmology, the journal of the Royal Australia and NZ College of Ophthalmologists, a post he held for a decade. He is a Specialist Advisor to the Therapeutic Goods Administration.

A/Prof Qureshi attended the University of Adelaide Medical School graduating in 1991.  His Ophthalmology training was at Flinders Medical Centre, the Royal Adelaide Hospital in South Australia. He then started the first of his two subspecialist fellowships at Leeds General Infirmary in Anterior Segment reconstruction and complex cataract surgery. In 2000, he started his second fellowship at Moorfields Eye Hospital in London with Professor Alan Bird in Medical Retina. He returned to Australia to join the Medical Retina Clinic at the Royal Victorian Eye and Ear Hospital (RVEEH) in 2001 as a consultant Ophthalmologist.

A/Prof Qureshi introduced anti-VEGF therapy (Avastin) for retinal vascular disease to the RVEEH, as lead clinician in 2006. As a result the Eye Hospital became the first hospital in Australia to offer this revolutionary therapy for blinding retinal disease. In 2013 he, along with A/Prof Lyndell Lim, commenced the DIMECAT trial that will change the way cataract surgery is performed in patients with diabetic eye disease. He has also been either a principal investigator or investigator in many of the landmark retinal clinical trials over the last 20 years including the ANCOR, MARINA, RESOLVE, and EXCITE trials. These trials, among others, have revolutionised the treatment of blinding retinal disease.

As Editor in Chief of Clinical and Experimental Ophthalmology for a decade from 2010 to 2020 he raised the impact factor and journal rank to the highest of any medical journal published in Australia and New Zealand.

A/Prof Qureshi has authored many peer reviewed papers in the international medical literature. He has also authored book chapters and published an Atlas of Retinal Disease for the iPhone and iPad.

A/Prof Qureshi’s surgical experience spans more than 20 years in complex Cataract Surgery, Intravitreous Injections and Retinal Laser. His areas of clinical specialty are Diabetic Eye Disease (retinopathy), Macular Degeneration, Retinal Vascular Disease and Inherited Retinal Disease (Retinal Dystrophies). He consults in Doncaster and Vermont South.

Request Appointment